Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 11, 2017
Previous Article Next Article

Photochemical internalization in bladder cancer – development of an orthotopic in vivo model

Author affiliations

Abstract

The possibility of using photochemical internalization (PCI) to enhance the effects of the cytotoxic drug bleomycin is investigated, together with photophysical determination and outlines of a possible treatment for intravesical therapy of bladder cancer. In vitro experiments indicated that the employment of PCI technology using the novel photosensitizer TPCS2a® can enhance the cytotoxic effect of bleomycin in bladder cancer cells. Furthermore, experiments in an orthotopic in vivo bladder cancer model show an effective reduction in both the necrotic area and the bladder weight after TPCS2a based photodynamic therapy (PDT). The tumor selectivity and PDT effects may be sufficient to destroy tumors without damaging the detrusor muscle layer. Our results present a possible new treatment strategy for non-muscle invasive bladder cancer, with the intravesical instillation of the photosensitizer and bleomycin followed by illumination through an optic fiber by using a catheter.

Graphical abstract: Photochemical internalization in bladder cancer – development of an orthotopic in vivo model

Back to tab navigation

Supplementary files

Article information


Submitted
16 May 2017
Accepted
01 Sep 2017
First published
08 Sep 2017

Photochem. Photobiol. Sci., 2017,16, 1664-1676
Article type
Paper

Photochemical internalization in bladder cancer – development of an orthotopic in vivo model

O. A. Gederaas, A. Johnsson, K. Berg, R. Manandhar, C. Shrestha, D. Skåre, I. K. Ekroll, A. Høgset and A. Hjelde, Photochem. Photobiol. Sci., 2017, 16, 1664
DOI: 10.1039/C7PP00176B

Social activity

Search articles by author

Spotlight

Advertisements